Carsten Brunn - Net Worth and Insider Trading
Carsten Brunn Net Worth
The estimated net worth of Carsten Brunn is at least $640,046 dollars as of 2024-10-05. Carsten Brunn is the President and CEO of Cartesian Therapeutics Inc and owns about 26,103 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $640,046. Details can be seen in Carsten Brunn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carsten Brunn has not made any transactions after 2023-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carsten Brunn
Carsten Brunn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carsten Brunn owns 2 companies in total, including Cartesian Therapeutics Inc (RNAC) , and Surface Oncology Inc (SURF) .
Click here to see the complete history of Carsten Brunn’s form 4 insider trades.
Insider Ownership Summary of Carsten Brunn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2023-09-25 | director & President & CEO |
| SURF | Surface Oncology Inc | 2022-06-28 | director |
Carsten Brunn Latest Holdings Summary
Carsten Brunn currently owns a total of 1 stock. Carsten Brunn owns 26,103 shares of Cartesian Therapeutics Inc (RNAC) as of September 25, 2023, with a value of $640,046.
Latest Holdings of Carsten Brunn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2023-09-25 | 26,103 | 24.52 | 640,046 |
Holding Weightings of Carsten Brunn
Carsten Brunn Form 4 Trading Tracker
According to the SEC Form 4 filings, Carsten Brunn has made a total of 15 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Cartesian Therapeutics Inc is the sale of 98 shares on September 25, 2023, which brought Carsten Brunn around $3,108.
Insider Trading History of Carsten Brunn
- 1
Carsten Brunn Trading Performance
Carsten Brunn Ownership Network
Carsten Brunn Owned Company Details
What does Cartesian Therapeutics Inc do?
Who are the key executives at Cartesian Therapeutics Inc?
Carsten Brunn is the director & President & CEO of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , Chief Scientific Officer Takashi Kei Kishimoto , and COO and SVP & R&D Lloyd P. Johnston .
Cartesian Therapeutics Inc (RNAC) Insider Trades Summary
Over the past 18 months, Carsten Brunn made 1 insider transaction in Cartesian Therapeutics Inc (RNAC) with a net sale of 2,932. Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,437,053 shares made by Timothy A Springer , a net purchase of 7,500 shares made by Timothy C Barabe , and a net sale of 705 shares made by Peter G Traber .
In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 221,237 shares, with a net purchase of 221,237 shares. During the past 18 months, 121 shares of Cartesian Therapeutics Inc (RNAC) were sold and 262,014 shares were bought by its insiders, resulting in a net purchase of 261,893 shares.
Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cartesian Therapeutics Inc Insider Transactions
Carsten Brunn Mailing Address
Above is the net worth, insider trading, and ownership report for Carsten Brunn. You might contact Carsten Brunn via mailing address: C/o Selecta Biosciences, Inc., 480 Arsenal Way, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
